Utilization of transgenic mice replicating high levels of hepatitis B virus for antiviral evaluation of lamivudine (Q28368198)

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Expression and replication of hepatitis B virus genome in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Hepatitis B virus immunopathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Current use of anti-HIV drugs in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Developmental regulation of hepatitis B surface antigen expression in two lines of hepatitis B virus transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Quantitative assay of PCR-amplified hepatitis B virus DNA using a peroxidase-labelled DNA probe and enhanced chemiluminescence.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Hepatitis B surface antigen gene expression is regulated by sex steroids and glucocorticoids in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

HBsAg retention sensitizes the hepatocyte to injury by physiological concentrations of interferon-gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

High-level hepatitis B virus replication in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

The hepatitis B virus (HBV) precore protein inhibits HBV replication in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Hepadnavirus infection of peripheral blood lymphocytes in vivo: woodchuck and chimpanzee models of viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Hepatocellular carcinoma in woodchuck hepatitis virus-infected woodchucks: presence of viral DNA in tumor tissue from chronic carriers and animals serologically recovered from acute infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Bovine papillomavirus genome elicits skin tumours in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Development of disease and virus recovery in transgenic mice containing HIV proviral DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

The interaction of human immunodeficiency virus infection and hepatitis B virus infection in infected homosexual men.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Prolonged interferon-alpha therapy of hepatitis B virus-related decompensated cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Impact of complete inhibition of viral replication on the cellular immune response in chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Is a function of the secreted hepatitis B e antigen to induce immunologic tolerance in utero?

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

In vivo inhibition of hepatitis B virus gene expression by antisense phosphorothioate oligonucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Inhibition of intrahepatic hepatitis B virus replication by antiviral drugs in a novel transgenic mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Recognition efficiency of the hepatitis B virus polyadenylation signals is tissue specific in transgenic mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Adaptation of orbital bleeding technic to rapid serial blood studies

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Potential role of lamivudine (3TC) in the clearance of chronic hepatitis B virus infection in a patient coinfected with human immunodeficiency virus type

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021

Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900009-1

7 January 2021